3 times QC before
delivery.
12-month shelf life.
Strong technical
support
Prompt response
After-sales service guarantee.
| > Cytokine |
| >Signal transduction |
| > Enzyme & Kinase |
| > Metabolic pathway |
| > Tumor immunity |
| > Infection immunity |
| > CD& Adhesion molecule |
| > Neuro science |
| > Developmental science |
FAQ
Anti-Human CD197/CCR7 Monoclonal Antibody(AF488 Conjugated)
| Product name: | Anti-Human CD197/CCR7 Monoclonal Antibody(AF488 Conjugated) | |
| Catalog: | DL21854F |
|
| Synonyms : | CMKBR7, EBI1, EVI1,CCR-7,CDw197 | |
| Reactivity: | Human | |
| Applications: | FCM | |
| Size: | 20 Tests/50 Tests/100 Tests/200 Tests | |
| Host: | Mouse | |
| Clonality: | ||
| Conjugation: | ||
| Background: | CCR7, also known as CD197, is a chemokine receptor that binds CCL19 and CCL21. CCR7 and its ligands link innate and adaptive immunity by affecting interactions between T cells and dendritic cells and their downstream effect. Na?ve T cells enter the lymph node through high endothelial venules, which express CCL21. Dendritic cells and macrophages enter the lymph node through afferent lymphatics. The encounter of T cells and dendritic cells in the T cell zone is CCR7-dependent. In addition, during immunological surveillance, B cells recirculate between B-cell-rich compartments (follicles or B cell zones) in secondary lymphoid organs, surveying for antigen. After antigen binding, B cells move to the boundary of B and T zones to interact with T-helper cells; this B cell migration is directed by CCR7 and its ligands. CCR7-positive cancer cell expression has been associated with lymph node metastasis. Product Details |
|
| Concentration: | ||
| Buffer: | PBS with 0.05% Proclin300, 1% BSA | |
| Gene_ID: | 1236 | |
| Clone_NO: | G043H7 | |
| SwissProt: | P32248 | |
| Isotype: | Mouse IgG2a, ? | |
| Storage: | Store at 2~8℃ and protected from prolonged exposure to light. Do not freeze. | |
Order or get a Quote
We will reply you within 24 hours!
